Measurement of the Effect of Positional Changes on Cerebral Oxygenation in Preterm Infants
This study has been completed.
Sponsor:
Zekai Tahir Burak Maternity and Teaching Hospital
Information provided by:
Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier:
NCT01255189
First received: December 2, 2010
Last updated: August 5, 2011
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Near infrared spectroscopy offers the possibility of noninvasive and continuous bedside investigation of cerebral oxygenation in newborn infants. Using this technique we investigated the effect of positional changes on cerebral oxygenation in preterm infants.
| Condition | Intervention | Phase |
|---|---|---|
|
pOSitional Changes of Premature Infants |
Device: Device: near infrared spectroscopy: INVOS 5100 Device: invos 5100 |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Measurement of the Effect of Positional Changes on Cerebral Oxygenation in Preterm Infants: A Near Infrared Spectroscopy Study |
Resource links provided by NLM:
Further study details as provided by Zekai Tahir Burak Maternity and Teaching Hospital:
Primary Outcome Measures:
- The effect of positional changes on cerebral oxygenation in preterm infants [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | December 2010 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Device: near infrared spectroscopy: invos 5100
NIRS device used in this study, the optical field includes a volume of tissue approximately 2 cm deep to the surface probe with a 4-mm source-detector distance, and thus, organ-specific monitoring is feasible in small patients. With informed consent, we applied NIRS probes to the forehead and the lower extremity for cerebral (rSO2C) and peripheric (rSO2P) regional oxygen saturation measurements
|
Device: Device: near infrared spectroscopy: INVOS 5100
NIRS device used in this study, the optical field includes a volume of tissue approximately 2 cm deep to the surface probe with a 4-mm source-detector distance, and thus, organ-specific monitoring is feasible in small patients. With informed consent, we applied NIRS probes to the forehead and the lower extremity for cerebral (rSO2C) and peripheric (rSO2P) regional oxygen saturation measurements.
Other Name: invos 5100
Device: invos 5100
near infrared spectroscopy: invos 5100
|
Detailed Description:
The changes in cerebral perfusion have an important role on the development of intraventricular hemorrhage and periventricular leucomalacia. Near infrared spectroscopy offers the possibility of noninvasive and continuous bedside investigation of cerebral oxygenation in newborn infants. Using this technique we investigated the effect of positional changes on cerebral oxygenation in preterm infants.
Eligibility| Ages Eligible for Study: | up to 2 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- <32 gestational age and/or <1500gr.
- >30th day preterm infants
Exclusion Criteria:
- sepsis
- shock
- severe intracranial hemorrhage
- NEC
- abdominal and cranial surgery
Contacts and Locations
More Information
No publications provided by Zekai Tahir Burak Maternity and Teaching Hospital
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Gamze Demirel, Neonatal Intensive Care Unit ( Zekai Tahir Burak Maternity and Teaching Hospital ) |
| ClinicalTrials.gov Identifier: | NCT01255189 History of Changes |
| Other Study ID Numbers: | 3498 |
| Study First Received: | December 2, 2010 |
| Last Updated: | August 5, 2011 |
| Health Authority: | Turkey: Ethics Committee |
Keywords provided by Zekai Tahir Burak Maternity and Teaching Hospital:
|
NIRS |
ClinicalTrials.gov processed this record on June 17, 2013